BHCBausch Health Companies Inc.

NYSE bauschhealth.com


$ 5.63 $ -0.47 (-7.7 %)    

Friday, 02-Aug-2024 15:59:49 EDT
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 5.63
$ 5.62 x 1,400
-- x --
-- - --
$ 3.96 - $ 11.46
3,560,821
na
2.07B
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 11-03-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-19-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-06-2019 03-31-2019 10-Q
23 02-20-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 02-28-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 06-07-2016 03-31-2016 10-Q
35 04-29-2016 12-31-2015 10-K
36 10-26-2015 09-30-2015 10-Q
37 07-28-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 10-24-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price ta...

 bausch-health-solvency-remains-a-concerns-analyst-downgrades-stock

Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper...

 piper-sandler-downgrades-bausch-health-companies-to-underweight-lowers-price-target-to-3

Piper Sandler analyst David Amsellem downgrades Bausch Health Companies (NYSE:BHC) from Neutral to Underweight and lowers th...

 us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

 wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

 apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

 truist-securities-maintains-hold-on-bausch-health-companies-lowers-price-target-to-7

Truist Securities analyst Gregory Fraser maintains Bausch Health Companies (NYSE:BHC) with a Hold and lowers the price targe...

 why-bausch-health-shares-are-falling-today

Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered b...

Core News & Articles

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® to...

 bausch-health-companies-says-jean-jacques-charhon-will-join-company-as-cfo-on-august-19-2024---filing

Upon JJ’s arrival, John Barresi, the Company’s Interim Chief Financial Officer, will resume his role as SVP, Controller. Also,...

 raymond-james-initiates-coverage-on-bausch-health-companies-with-market-perform-rating-announces-price-target-of-8

Raymond James analyst Michael Freeman initiates coverage on Bausch Health Companies (NYSE:BHC) with a Market Perform rating ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION